These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2191888)

  • 61. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients.
    McGill JB; Schneider DJ; Arfken CL; Lucore CL; Sobel BE
    Diabetes; 1994 Jan; 43(1):104-9. PubMed ID: 8262307
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thermic effect of glucose in obese subjects with non-insulin-dependent diabetes mellitus.
    Ravussin E; Zawadzki JK
    Diabetes; 1987 Dec; 36(12):1441-7. PubMed ID: 3315790
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
    Luzi L; Petrides AS; De Fronzo RA
    Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity?
    Bastard JP; Bruckert E; Robert JJ; Ankri A; Grimaldi A; Jardel C; Hainque B
    Int J Obes Relat Metab Disord; 1995 Nov; 19(11):836-8. PubMed ID: 8589788
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects.
    Paolisso G; Sgambato S; Pizza G; Passariello N; Varricchio M; D'Onofrio F
    Diabetes Care; 1989 Apr; 12(4):265-9. PubMed ID: 2651054
    [TBL] [Abstract][Full Text] [Related]  

  • 67. IGF-I--stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM.
    Dohm GL; Elton CW; Raju MS; Mooney ND; DiMarchi R; Pories WJ; Flickinger EG; Atkinson SM; Caro JF
    Diabetes; 1990 Sep; 39(9):1028-32. PubMed ID: 2166697
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lipoprotein(a) in android obesity and NIDDM.
    Wassef N; Sidhom G; Zakareya el-K ; Mohamed el-K
    Diabetes Care; 1997 Nov; 20(11):1693-6. PubMed ID: 9353610
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytosolic Ca profile of resting and thrombin-stimulated platelets from black women with NIDDM.
    Zentay Z; Raguwanshi M; Reddi A; Lasker N; Dasmahapatra A; Aviv A
    J Diabetes Complications; 1995; 9(2):74-80. PubMed ID: 7599351
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus.
    Prager R; Schernthaner G; Graf H
    Diabete Metab; 1986 Dec; 12(6):346-50. PubMed ID: 3817257
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes.
    Pedersen O; Nielsen O; Bak J; Richelsen B; Beck-Nielsen H; Sørensen N
    Diabet Med; 1989 Apr; 6(3):249-56. PubMed ID: 2523787
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Circulating insulin-like growth factor I concentrations in clinically severe obese patients with and without NIDDM in response to weight loss.
    Poulos JE; Leggett-Frazier N; Khazanie P; Long S; Sportsman R; MacDonald K; Caro JF
    Horm Metab Res; 1994 Oct; 26(10):478-80. PubMed ID: 7851872
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of obese NIDDM and nondiabetic women: short- and long-term weight loss.
    Guare JC; Wing RR; Grant A
    Obes Res; 1995 Jul; 3(4):329-35. PubMed ID: 8521149
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Absorption of rapid-acting insulin in obese and nonobese NIDDM patients.
    Clauson PG; Linde B
    Diabetes Care; 1995 Jul; 18(7):986-91. PubMed ID: 7555561
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Insulin binding to circulating monocytes in children with insulin-dependent and non-insulin-dependent diabetes mellitus.
    Kida K; Goto Y; Watanabe N; Kaino Y; Miyagawa T; Inoue T; Ikeuchi M; Matsuda H; Kuwajima K
    Diabetes Res Clin Pract; 1988 Feb; 4(3):161-6. PubMed ID: 3282856
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Plasma glucose and insulin response to macronutrients in nondiabetic and NIDDM subjects.
    Nuttall FQ; Gannon MC
    Diabetes Care; 1991 Sep; 14(9):824-38. PubMed ID: 1959475
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus.
    Rizza RA; Mandarino LJ; Gerich JE
    Diabetes; 1981 Dec; 30(12):990-5. PubMed ID: 7030834
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of metformin on liver blood flow in vivo in normal subjects and patients with non insulin dependent diabetes.
    Signore A; Fiore V; Chianelli M; Procaccini E; Barone R; Ronga G; Negri M; Pozzilli P
    Diabetes Res Clin Pract; 1996 Jul; 33(2):83-7. PubMed ID: 8879962
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects.
    Niskanen LK; Uusitupa MI; Sarlund H; Siitonen O; Pyörälä K
    Diabetes Care; 1990 Jan; 13(1):41-8. PubMed ID: 2404716
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Respiratory burst activity of monocytes from patients with non-insulin-dependent diabetes mellitus.
    Chang FY; Shaio MF
    Diabetes Res Clin Pract; 1995 Aug; 29(2):121-7. PubMed ID: 8591699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.